TLPH Q4 2022 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q4 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$252,000+12500.0% YoY

Gross Profit

-$110,000-43.7% margin

Operating Income

-$7M-2931.0% margin

Net Income

-$7M-2969.8% margin

EPS (Diluted)

$-1.00

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$628,000

Balance Sheet

Total Assets

$47M

Total Liabilities

$26M

Stockholders' Equity

$22M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$252,000	$2,000	+12500.0%
Gross Profit	-$110,000	-$1M	+91.1%
Operating Income	-$7M	-$8M	+9.7%
Net Income	-$7M	-$8M	+5.5%